Warning: The NCBI web site requires JavaScript to function. more...
Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.
Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO.
Malar J. 2008 Jun 11;7:107.
Related citations
Pharmacovigilance of antimalarial treatment in Africa: is it possible?
Talisuna AO, Staedke SG, D'Alessandro U.
Malar J. 2006 Jun 16;5:50.
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG.
Malar J. 2008 Jun 11;7:106.
High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G.
Clin Infect Dis. 2008 Apr 1;46(7):985-91.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P.
Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. Review.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
Katrak S, Gasasira A, Arinaitwe E, Kakuru A, Wanzira H, Bigira V, Sandison TG, Homsy J, Tappero JW, Kamya MR, Dorsey G.
Malar J. 2009 Nov 30;8:272.
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyer G, Sapuri M.
Malar J. 2009 Aug 12;8:196.
The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.
Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR.
Malar J. 2009 Mar 16;8:48.
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H.
PLoS One. 2008 Jun 11;3(6):e2390.
Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.
Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M.
BMC Infect Dis. 2008 Mar 28;8:39. Review.
Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
Kuemmerle A, Dodoo AN, Olsson S, Van Erps J, Burri C, Lalvani PS.
Malar J. 2011 Mar 9;10:57.
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G.
PLoS Med. 2005 Jul;2(7):e190. Epub 2005 Jul 26.
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, Janssens B, Mayxay M, Newton P, Singhasivanon P, Stepniewska K, White NJ, Nosten F.
PLoS One. 2009 Jul 29;4(7):e6358.
Adverse event monitoring of artemesinin combination therapy in Nigeria: the challenges and limitations of the study.
Oshikoya KA.
West Afr J Med. 2010 Jul-Aug;29(4):221-4.
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ.
JAMA. 2007 May 23;297(20):2210-9.
Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
[No authors listed]
Prescrire Int. 2008 Apr;17(94):54-6.
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ.
Malar J. 2008 Jul 11;7:127.
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
Osorio L, Gonzalez I, Olliaro P, Taylor WR.
Malar J. 2007 Feb 28;6:25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on